These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18289073)

  • 1. Carbon monoxide-releasing molecules: a pharmacological expedient to counteract inflammation.
    Alcaraz MJ; Guillen MI; Ferrandiz ML; Megías J; Motterlini R
    Curr Pharm Des; 2008; 14(5):465-72. PubMed ID: 18289073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation.
    Ryter SW; Choi AM
    Transl Res; 2016 Jan; 167(1):7-34. PubMed ID: 26166253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of carbon monoxide-releasing molecules.
    Motterlini R; Mann BE; Foresti R
    Expert Opin Investig Drugs; 2005 Nov; 14(11):1305-18. PubMed ID: 16255672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of Heme Oxygenase-1/carbon Monoxide System Against Ischemia-Reperfusion Injury.
    Cheng Y; Rong J
    Curr Pharm Des; 2017; 23(26):3884-3898. PubMed ID: 28412905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharide.
    Motterlini R; Nikam A; Manin S; Ollivier A; Wilson JL; Djouadi S; Muchova L; Martens T; Rivard M; Foresti R
    Redox Biol; 2019 Jan; 20():334-348. PubMed ID: 30391826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential.
    Paine A; Eiz-Vesper B; Blasczyk R; Immenschuh S
    Biochem Pharmacol; 2010 Dec; 80(12):1895-903. PubMed ID: 20643109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages.
    Sawle P; Foresti R; Mann BE; Johnson TR; Green CJ; Motterlini R
    Br J Pharmacol; 2005 Jul; 145(6):800-10. PubMed ID: 15880142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme oxygenase-1 as a target for drug discovery.
    Motterlini R; Foresti R
    Antioxid Redox Signal; 2014 Apr; 20(11):1810-26. PubMed ID: 24180608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme oxygenase-1/carbon monoxide as modulators of autophagy and inflammation.
    Ryter SW
    Arch Biochem Biophys; 2019 Dec; 678():108186. PubMed ID: 31704095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon Monoxide Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by the Cyclic GMP/Protein Kinase G and NF-κB Signaling Pathway.
    Zhang A; Zhao L; Li N; Duan H; Liu H; Pu F; Zhang G; Zhou EM; Xiao S
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis.
    Ferrándiz ML; Maicas N; Garcia-Arnandis I; Terencio MC; Motterlini R; Devesa I; Joosten LA; van den Berg WB; Alcaraz MJ
    Ann Rheum Dis; 2008 Sep; 67(9):1211-7. PubMed ID: 18063671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease.
    Naito Y; Takagi T; Yoshikawa T
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():177-84. PubMed ID: 15298625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide: mechanisms of action and potential clinical implications.
    Rochette L; Cottin Y; Zeller M; Vergely C
    Pharmacol Ther; 2013 Feb; 137(2):133-52. PubMed ID: 23026155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy.
    Pae HO; Lee YC; Chung HT
    Recent Pat Inflamm Allergy Drug Discov; 2008 Nov; 2(3):159-65. PubMed ID: 19076005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide alleviates ethanol-induced oxidative damage and inflammatory stress through activating p38 MAPK pathway.
    Li Y; Gao C; Shi Y; Tang Y; Liu L; Xiong T; Du M; Xing M; Liu L; Yao P
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):53-8. PubMed ID: 23994557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of carbon monoxide in multiple sclerosis.
    Fagone P; Mangano K; Coco M; Perciavalle V; Garotta G; Romao CC; Nicoletti F
    Clin Exp Immunol; 2012 Feb; 167(2):179-87. PubMed ID: 22235993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme oxygenase-1 and carbon monoxide in pulmonary medicine.
    Slebos DJ; Ryter SW; Choi AM
    Respir Res; 2003; 4(1):7. PubMed ID: 12964953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities.
    Motterlini R
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1142-6. PubMed ID: 17956297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the 'silent killer'.
    Chatterjee PK
    Br J Pharmacol; 2004 Jun; 142(3):391-3. PubMed ID: 15148242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized delivery of carbon monoxide.
    Steiger C; Hermann C; Meinel L
    Eur J Pharm Biopharm; 2017 Sep; 118():3-12. PubMed ID: 27836646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.